Posted June 5, 2013
Sam Gandy, M.D., Ph.D., and Scott Noggle, Ph.D., explained their roles in Cure Alzheimer’s Fund’s Stem Cell Consortium in a discussion with author David Shenk. Topics covered include induced pluripotent stem cells, the benefits of using this technique as a tool in Alzheimer’s research and the steps toward drug discovery.
